Filing Details

Accession Number:
0001209191-15-005333
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-20 21:00:34
Reporting Period:
2015-01-16
Filing Date:
2015-01-20
Accepted Time:
2015-01-20 21:00:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1463729 Receptos Inc. RCPT Pharmaceutical Preparations (2834) 264190792
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553179 Waage Christian 3033 Science Park, Suite 300
San Diego CA 92121
Svp & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-09-16 25,000 $22.65 25,000 No 4 M Direct
Common Stock Disposition 2014-09-16 25,000 $107.05 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2015-01-16 25,000 $0.00 25,000 $22.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
125,000 2023-11-24 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.33 to $110.78 per share, inclusive. The reporting person undertakes to provide to Receptos, Inc., any security holder of Receptos, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The option, representing a right to purchase a total of 150,000 shares, became exercisable as follows: 25% on the one-year anniversary of November 25, 2013 and 1/48th of the shares vest each month thereafter for the remaining three years. The option is subject to vesting acceleration in the event of certain corporate or change of control transactions.